Blueprint Medicines Corpo... (BPMC)
88.69
-1.04 (-1.16%)
At close: Mar 28, 2025, 3:59 PM
88.72
0.03%
After-hours: Mar 28, 2025, 04:05 PM EDT
Blueprint Medicines Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 508.82M | 249.38M | 204.04M | 180.08M | 793.74M | 66.51M | 44.52M | 21.43M | 27.77M | 11.4M | n/a | n/a |
| Cost of Revenue | 20.16M | 12.8M | 17.81M | 17.93M | 425K | n/a | 243.62M | 144.69M | 81.13M | 48.59M | 31.84M | 15.93M |
| Gross Profit | 488.66M | 236.58M | 186.22M | 162.15M | 793.31M | 66.51M | -199.1M | -123.26M | -53.36M | -37.19M | -31.84M | -15.93M |
| Operating Income | -212.04M | -486.28M | -549.25M | -648.46M | 302.15M | -366.58M | -247.03M | -149.48M | -73.61M | -53.02M | -39.83M | -20.77M |
| Interest Income | 40.66M | n/a | 17.75M | 2.39M | 6.6M | 13.73M | 10.64M | 3.42M | n/a | n/a | n/a | n/a |
| Pretax Income | -65.86M | -506.02M | -552.28M | -641.08M | 314.94M | -347.69M | -236.64M | -148.12M | -72.5M | -52.77M | -40.28M | -20.91M |
| Net Income | -67.09M | -506.98M | -557.52M | -644.09M | 313.88M | -328.7M | -236.64M | -148.12M | -72.5M | -52.77M | -40.28M | -20.91M |
| Selling & General & Admin | 359.27M | 295.14M | 237.37M | 195.29M | 157.74M | 96.39M | 47.93M | 27.99M | 19.22M | 14.46M | 7.89M | 5.07M |
| Research & Development | 341.43M | 427.72M | 477.42M | 601.03M | 326.86M | 331.45M | 243.62M | 144.69M | 81.13M | 48.59M | 31.84M | 15.93M |
| Other Expenses | n/a | n/a | 8.95M | 7.8M | -366K | -100K | 10.46M | 3.35M | 551K | -429K | -98K | 226K |
| Operating Expenses | 700.71M | 722.86M | 723.74M | 804.13M | 484.6M | 427.84M | 291.55M | 172.67M | 100.35M | 63.04M | 39.73M | 21M |
| Interest Expense | 68.81M | n/a | 16.77M | n/a | n/a | 13.73M | 73K | 221K | 469K | 696K | 453K | 138K |
| Selling & Marketing Expenses | 96.6M | 16.9M | 18.1M | 13.5M | 9.4M | 3.3M | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 720.87M | 735.66M | 741.55M | 822.06M | 485.03M | 427.84M | 291.55M | 172.67M | 100.35M | 63.04M | 39.73M | 21M |
| Income Tax | 1.23M | 968K | 5.24M | 3M | 1.06M | -18.99M | 10.46M | 1.99M | -562K | -681K | 355K | 364K |
| Shares Outstanding (Basic) | 62.86M | 60.56M | 59.64M | 58.52M | 54.53M | 47.83M | 43.87M | 37.79M | 27.49M | 18.24M | 13.08M | 13.08M |
| Shares Outstanding (Diluted) | 62.86M | 60.56M | 59.64M | 58.52M | 56.17M | 47.83M | 43.87M | 37.79M | 27.49M | 18.24M | 13.08M | 13.08M |
| EPS (Basic) | -1.07 | -8.37 | -9.35 | -11.01 | 5.76 | -6.87 | -5.39 | -3.92 | -2.64 | -2.89 | -3.08 | -1.6 |
| EPS (Diluted) | -1.07 | -8.37 | -9.35 | -11.01 | 5.59 | -6.87 | -5.39 | -3.92 | -2.64 | -2.89 | -3.08 | -1.6 |
| EBITDA | -212.04M | -470.36M | -515.41M | -628.3M | 308.71M | -356.07M | -242.78M | -149.67M | -70.44M | -51.13M | -39.11M | -20.5M |
| Depreciation & Amortization | 16.29M | 11.66M | 20.1M | 12.79M | 12.35M | 10.25M | 4.25M | 1.58M | 1.58M | 948K | 622K | 501K |